A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy Subjects

NCT02500953 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male Subjects

Interventions

DRUG: ASP3325
DRUG: Placebo

Sponsor

Astellas Pharma Inc